SIC 8731 – Commercial Physical and Biological Research
| Valuation | |
|---|---|
| Market Cap ($M) | 5,090.35 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 1,435.33 |
| Book Value / Share | 112.79 |
| Price / Book | n/a |
| NCAV ($M) | 170.15 |
| NCAV / Share | 13.37 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.04 |
| Return on Assets (ROA) | 0.03 |
| Return on Equity (ROE) | 0.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.18 |
| Current Ratio | 1.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 856.31 |
| Assets | 2,121.48 |
| Liabilities | 686.15 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 934.28 |
| Operating Income | 75.57 |
| Net Income | 67.66 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 148.54 |
| Cash from Investing | -48.61 |
| Cash from Financing | -81.30 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| ORYZF – Oryzon Genomics S.A. | PXMTF – PHAXIAM Therapeutics S.A. |
| SGSOF – SGS SA | USRM – U.S. Stem Cell, Inc. |
| VSBC – VitaSpring Biomedical Co. Ltd. |
Financial data and stock pages provided by
Fintel.io